Sava deadline: rosen law firm urges cassava sciences, inc. (nasdaq: sava) stockholders with large losses to contact the firm for information about their rights

New york--(business wire)--rosen law firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of cassava sciences, inc. (nasdaq: sava) between february 7, 2024 and november 24, 2024. cassava describes itself as a “clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.” for more information, submit a form, email attorney phillip kim, or give us a call at 866-767-365.
sava Ratings Summary
sava Quant Ranking